Literature DB >> 30217592

The Role of Colchicine in Treating Postoperative and Post-catheter Ablation Atrial Fibrillation.

Spyridon G Deftereos1, Dimitrios A Vrachatis2, Christos Angelidis1, Agathi-Rosa Vrettou1, Eleni K Sarri3, Sotiria G Giotaki3, Efthymia Varytimiadi1, Charalampos Kossyvakis3, Eleana Kotsia3, Gerasimos S Deftereos3, Konstantinos Doudoumis3, Georgios Giannopoulos3.   

Abstract

PURPOSE: The goal of this review was to summarize, analyze, and compare trials studying the efficacy of colchicine in the prevention of atrial fibrillation (AF) post-operatively (POAF) and post-catheter ablation. Ongoing studies and current guidelines are also presented and reviewed.
METHODS: Published studies on the field were identified through a literature search of the PubMed and clinicaltrials.gov databases.
FINDINGS: Four original studies regarding POAF, two original studies regarding post-catheter ablation AF, and six meta-analyses were identified. In addition, the 3 most recent guidelines/expert consensus documents were scrutinized. IMPLICATIONS: AF occurs frequently after cardiac surgery (POAF) and catheter pulmonary vein isolation (postablation AF) and is associated with increased cardiovascular morbidity. A number of trials over the last few years have investigated the role of colchicine in the prevention of POAF and postablation AF targeting the local and systemic inflammatory process that leads to initiation and maintenance of AF. Available data imply that colchicine may have a preventive role in POAF and/or postablation AF. However, certain limitations of these studies underline the need for further investigation.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  POAF; cardiac surgery; catheter ablation; cryoablation; cryoballoon; radiofrequency

Year:  2018        PMID: 30217592     DOI: 10.1016/j.clinthera.2018.08.008

Source DB:  PubMed          Journal:  Clin Ther        ISSN: 0149-2918            Impact factor:   3.393


  6 in total

Review 1.  Arrhythmogenic Substrates for Atrial Fibrillation in Obesity.

Authors:  Ellen R Lubbers; Morgan V Price; Peter J Mohler
Journal:  Front Physiol       Date:  2018-10-22       Impact factor: 4.566

Review 2.  Immunologic Dysregulation and Hypercoagulability as a Pathophysiologic Background in COVID-19 Infection and the Immunomodulating Role of Colchicine.

Authors:  Dimitrios A Vrachatis; Konstantinos A Papathanasiou; Sotiria G Giotaki; Konstantinos Raisakis; Charalampos Kossyvakis; Andreas Kaoukis; Fotis Kolokathis; Gerasimos Deftereos; Konstantinos E Iliodromitis; Dimitrios Avramides; Harilaos Bogossian; Gerasimos Siasos; George Giannopoulos; Bernhard Reimers; Alexandra Lansky; Jean-Claude Tardif; Spyridon Deftereos
Journal:  J Clin Med       Date:  2021-10-31       Impact factor: 4.241

Review 3.  A meta-analysis of colchicine in prevention of atrial fibrillation following cardiothoracic surgery or cardiac intervention.

Authors:  Hong Zhao; Yueming Chen; Min Mao; Jun Yang; Jing Chang
Journal:  J Cardiothorac Surg       Date:  2022-09-01       Impact factor: 1.522

Review 4.  Benefits and adverse effects of hydroxychloroquine, methotrexate and colchicine: searching for repurposable drug candidates.

Authors:  Durga Prasanna Misra; Armen Yuri Gasparyan; Olena Zimba
Journal:  Rheumatol Int       Date:  2020-09-02       Impact factor: 2.631

Review 5.  Gout Pharmacotherapy in Cardiovascular Diseases: A Review of Utility and Outcomes.

Authors:  Subuhi Kaul; Manasvi Gupta; Dhrubajyoti Bandyopadhyay; Adrija Hajra; Prakash Deedwania; Edward Roddy; Mamas Mamas; Allan Klein; Carl J Lavie; Gregg C Fonarow; Raktim K Ghosh
Journal:  Am J Cardiovasc Drugs       Date:  2020-12-28       Impact factor: 3.571

6.  Inflammation, atrial fibrillation, and the potential role for colchicine therapy.

Authors:  Bibin Varghese; David I Feldman; Christopher Chew; Eva Valilis; Roger S Blumenthal; Garima Sharma; Hugh Calkins
Journal:  Heart Rhythm O2       Date:  2021-04-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.